Boehringer - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Boehringer begins enrolment in Phase II BALANCE-CF1 trial

Boehringer
Boehringer’s BI 1265162 prevents the absorption of sodium. Credit: Boehringer Ingelheim.